Reuters Health: Merkel cell cancers recur more often than other skin cancers

UC expert says early detection of recurrence is important for treatment

New research shows that Merkel cell carcinoma (MCC) recurs in patients much more often than other skin cancers, often within three years of diagnosis.

MCC is a more rare skin cancer that usually appears as a flesh-colored or bluish-red nodule on the skin, often on the face, head or neck.

Rekha Chaudhary, MD, adjunct associate professor at the UC College of Medicine and a UC Health oncologist, reviewed the research and told Reuters Health that new immunotherapy treatments have proven effective against MCC recurrence, making early detection of recurrence important.

"This study was very helpful in predicting those rates of recurrence," she said. "Following an MCC patient who has had a complete resection closely is very important now, given the new innovative treatments, and national guidelines should be adjusted accordingly."

Read the Reuters Health article.

Featured photo at top of Dr. Chaudhary. Photo/Colleen Kelley/University of Cincinnati.

Related Stories

1

Decade of discovery

July 27, 2026

Every summer, UHP Discover has connected undergraduate students in the University Honors Program (UHP) to a unique array of opportunities in original interdisciplinary research. This year, the program celebrates its 10th anniversary.

2

Building community

July 27, 2026

The inaugural Ultra-SLP Conference brought together clinicians and researchers from across the country to advance the practice of using ultrasound technology to treat disorders of speech and swallowing.

3

The subtle changes in hearing you should never ignore

July 24, 2026

It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.